Publication: Toward Understanding the Impact of Dimerization Interfaces in Angiotensin II Type 1 Receptor
| dc.contributor.author | Erol, Ismail | |
| dc.contributor.author | Çoşut, Bünyemin | |
| dc.contributor.author | Durdagi, Serdar | |
| dc.contributor.institution | Erol, Ismail, Department of Chemistry, Gebze Teknik Üniversitesi, Gebze, Turkey, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey | |
| dc.contributor.institution | Çoşut, Bünyemin, Department of Chemistry, Gebze Teknik Üniversitesi, Gebze, Turkey | |
| dc.contributor.institution | Durdagi, Serdar, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey, Neuroscience Program, Bahçeşehir Üniversitesi, Istanbul, Turkey | |
| dc.date.accessioned | 2025-10-05T16:03:16Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Angiotensin II type 1 receptor (AT1R) is a prototypical class A G protein-coupled receptor (GPCR) that has an important role in cardiovascular pathologies and blood pressure regulation as well as in the central nervous system. GPCRs may exist and function as monomers, however, they can assemble to form higher order structures, and as a result of oligomerization, their function and signaling profiles can be altered. In the case of AT1R, the classical Gα<inf>q/11</inf> pathway is initiated with endogenous agonist angiotensin II binding. A variety of cardiovascular pathologies such as heart failure, diabetic nephropathy, atherosclerosis, and hypertension are associated with this pathway. Recent findings reveal that AT1R can form homodimers and activate the noncanonical (β-arrestin-mediated) pathway. Nevertheless, the exact dimerization interface and atomic details of AT1R homodimerization have not been still elucidated. Here, six different symmetrical dimer interfaces of AT1R are considered, and homodimers were constructed using other published GPCR crystal dimer interfaces as template structures. These AT1R homodimers were then inserted into the model membrane bilayers and subjected to all-atom molecular dynamics simulations. Our simulation results along with the principal component analysis and water pathway analysis suggest four different interfaces as the most plausible: symmetrical transmembrane (TM)1,2,8, TM5, TM4, and TM4,5 AT1R dimer interfaces that consist of one inactive and one active protomer. Moreover, we identified ILE2386.33 as a hub residue in the stabilization of the inactive state of AT1R. © 2024 Elsevier B.V., All rights reserved. | |
| dc.identifier.doi | 10.1021/acs.jcim.9b00294 | |
| dc.identifier.endpage | 4327 | |
| dc.identifier.issn | 1549960X | |
| dc.identifier.issn | 15499596 | |
| dc.identifier.issue | 10 | |
| dc.identifier.pubmed | 31429557 | |
| dc.identifier.scopus | 2-s2.0-85072831833 | |
| dc.identifier.startpage | 4314 | |
| dc.identifier.uri | https://doi.org/10.1021/acs.jcim.9b00294 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14719/11342 | |
| dc.identifier.volume | 59 | |
| dc.language.iso | en | |
| dc.publisher | American Chemical Society | |
| dc.relation.source | Journal of Chemical Information and Modeling | |
| dc.subject.authorkeywords | Receptor, Angiotensin, Type 1 | |
| dc.subject.authorkeywords | Blood Pressure | |
| dc.subject.authorkeywords | Dimerization | |
| dc.subject.authorkeywords | Dimers | |
| dc.subject.authorkeywords | Diseases | |
| dc.subject.authorkeywords | Molecular Dynamics | |
| dc.subject.authorkeywords | Principal Component Analysis | |
| dc.subject.authorkeywords | Angiotensin Ii | |
| dc.subject.authorkeywords | Blood Pressure Regulation | |
| dc.subject.authorkeywords | Central Nervous Systems | |
| dc.subject.authorkeywords | Class A | |
| dc.subject.authorkeywords | Dimer Interface | |
| dc.subject.authorkeywords | Dimerizations | |
| dc.subject.authorkeywords | G Protein Coupled Receptors | |
| dc.subject.authorkeywords | High-order Structure | |
| dc.subject.authorkeywords | Higher-order Structure | |
| dc.subject.authorkeywords | Homodimers | |
| dc.subject.authorkeywords | Pathology | |
| dc.subject.authorkeywords | Angiotensin 1 Receptor | |
| dc.subject.authorkeywords | Chemistry | |
| dc.subject.authorkeywords | Dimerization | |
| dc.subject.authorkeywords | Human | |
| dc.subject.authorkeywords | Molecular Dynamics | |
| dc.subject.authorkeywords | Molecular Model | |
| dc.subject.authorkeywords | Principal Component Analysis | |
| dc.subject.authorkeywords | Protein Conformation | |
| dc.subject.authorkeywords | Humans | |
| dc.subject.authorkeywords | Models, Molecular | |
| dc.subject.authorkeywords | Molecular Dynamics Simulation | |
| dc.subject.authorkeywords | Principal Component Analysis | |
| dc.subject.authorkeywords | Protein Conformation | |
| dc.subject.authorkeywords | Receptor, Angiotensin, Type 1 | |
| dc.subject.indexkeywords | Blood pressure | |
| dc.subject.indexkeywords | Dimerization | |
| dc.subject.indexkeywords | Dimers | |
| dc.subject.indexkeywords | Diseases | |
| dc.subject.indexkeywords | Molecular dynamics | |
| dc.subject.indexkeywords | Principal component analysis | |
| dc.subject.indexkeywords | Angiotensin II | |
| dc.subject.indexkeywords | Blood pressure regulation | |
| dc.subject.indexkeywords | Central nervous systems | |
| dc.subject.indexkeywords | Class A | |
| dc.subject.indexkeywords | Dimer interface | |
| dc.subject.indexkeywords | Dimerizations | |
| dc.subject.indexkeywords | G protein coupled receptors | |
| dc.subject.indexkeywords | High-order structure | |
| dc.subject.indexkeywords | Higher-order structure | |
| dc.subject.indexkeywords | Homodimers | |
| dc.subject.indexkeywords | Pathology | |
| dc.subject.indexkeywords | angiotensin 1 receptor | |
| dc.subject.indexkeywords | chemistry | |
| dc.subject.indexkeywords | dimerization | |
| dc.subject.indexkeywords | human | |
| dc.subject.indexkeywords | molecular dynamics | |
| dc.subject.indexkeywords | molecular model | |
| dc.subject.indexkeywords | principal component analysis | |
| dc.subject.indexkeywords | protein conformation | |
| dc.subject.indexkeywords | Humans | |
| dc.subject.indexkeywords | Models, Molecular | |
| dc.subject.indexkeywords | Molecular Dynamics Simulation | |
| dc.subject.indexkeywords | Principal Component Analysis | |
| dc.subject.indexkeywords | Protein Conformation | |
| dc.subject.indexkeywords | Receptor, Angiotensin, Type 1 | |
| dc.title | Toward Understanding the Impact of Dimerization Interfaces in Angiotensin II Type 1 Receptor | |
| dc.type | Article | |
| dcterms.references | Hauser, Alexander Sebastian, Trends in GPCR drug discovery: New agents, targets and indications, Nature Reviews Drug Discovery, 16, 12, pp. 829-842, (2017), Hauser, Alexander Sebastian, Pharmacogenomics of GPCR Drug Targets, Cell, 172, 1-2, pp. 41-54.e19, (2018), Whorton, Matthew R., A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein, Proceedings of the National Academy of Sciences of the United States of America, 104, 18, pp. 7682-7687, (2007), Ferré, Sergi, Oligomerization of G-protein-coupled receptors: A reality, Current Opinion in Pharmacology, 10, 1, pp. 1-5, (2010), Ferré, Sergi, G protein-coupled receptor oligomerization revisited: Functional and pharmacological perspectives, Pharmacological Reviews, 66, 2, pp. 413-434, (2014), Rasmussen, Sǒren G.F., Crystal structure of the human β2 adrenergic G-protein-coupled receptor, Nature, 450, 7168, pp. 383-387, (2007), Park, Jung-hee, Crystal structure of the ligand-free G-protein-coupled receptor opsin, Nature, 454, 7201, pp. 183-187, (2008), Wu, Beili, Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists, Science, 330, 6007, pp. 1066-1071, (2010), Manglik, Aashish, Crystal structure of the μ-opioid receptor bound to a morphinan antagonist, Nature, 485, 7398, pp. 321-326, (2012), Thompson, Aaron A., Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic, Nature, 485, 7398, pp. 395-399, (2012) | |
| dspace.entity.type | Publication | |
| local.indexed.at | Scopus | |
| person.identifier.scopus-author-id | 56531652600 | |
| person.identifier.scopus-author-id | 15135182300 | |
| person.identifier.scopus-author-id | 22955598300 |
